
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8394218
[patent_doc_number] => 20120232057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/480749
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71636
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13480749
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/480749 | Chiral fused [1,2]imidazo[4,5-c] ring compounds | May 24, 2012 | Issued |
Array
(
[id] => 8394229
[patent_doc_number] => 20120232071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => '2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/477217
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66167
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477217
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477217 | 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | May 21, 2012 | Issued |
Array
(
[id] => 8394193
[patent_doc_number] => 20120232036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/475037
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30451
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475037 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | May 17, 2012 | Issued |
Array
(
[id] => 10961571
[patent_doc_number] => 20140364601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'PROCESS'
[patent_app_type] => utility
[patent_app_number] => 14/117259
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12421
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117259
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117259 | PROCESS | May 10, 2012 | Abandoned |
Array
(
[id] => 8921000
[patent_doc_number] => 08486935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine'
[patent_app_type] => utility
[patent_app_number] => 13/467850
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9131
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467850
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467850 | Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine | May 8, 2012 | Issued |
Array
(
[id] => 8496492
[patent_doc_number] => 20120295900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => '1,3-OXAZINES AS BACE 1 AND/OR BACE2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/467085
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50388
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467085 | 1,3-oxazines as BACE 1 and/or BACE2 inhibitors | May 8, 2012 | Issued |
Array
(
[id] => 9370949
[patent_doc_number] => 20140080822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Tricyclic Pyrazole Sulphonamide Compounds and Methods of Making and Using Same'
[patent_app_type] => utility
[patent_app_number] => 14/116029
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37203
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116029
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116029 | Tricyclic pyrazole sulphonamide compunds and methods of making and using same | May 6, 2012 | Issued |
Array
(
[id] => 8784727
[patent_doc_number] => 08431570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Methods of utilizing arylpiperazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/465439
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15043
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465439
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465439 | Methods of utilizing arylpiperazine derivatives | May 6, 2012 | Issued |
Array
(
[id] => 8371184
[patent_doc_number] => 20120220574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/465549
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15044
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465549
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465549 | Methods of utilizing arylpiperazine derivatives | May 6, 2012 | Issued |
Array
(
[id] => 9370916
[patent_doc_number] => 20140080788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/113593
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 213024
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113593
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113593 | Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators | Apr 26, 2012 | Issued |
Array
(
[id] => 10857579
[patent_doc_number] => 08883779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them'
[patent_app_type] => utility
[patent_app_number] => 14/113327
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41747
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113327 | Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them | Apr 24, 2012 | Issued |
Array
(
[id] => 8406383
[patent_doc_number] => 20120238450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'C2-PHENYL-SUBSTITUTED CYCLIC KETONOLS'
[patent_app_type] => utility
[patent_app_number] => 13/455416
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34967
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13455416
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/455416 | C2-phenyl-substituted cyclic ketonols | Apr 24, 2012 | Issued |
Array
(
[id] => 9671764
[patent_doc_number] => 20140235626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'PYRIDINE DERIVATIVES AND A PHARMACEUTICAL COMPOSITION FOR INHIBITING BACE1 CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/112400
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46216
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112400 | PYRIDINE DERIVATIVES AND A PHARMACEUTICAL COMPOSITION FOR INHIBITING BACE1 CONTAINING THEM | Apr 24, 2012 | Abandoned |
Array
(
[id] => 8465685
[patent_doc_number] => 20120270854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'Antiviral Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/451608
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22746
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/451608 | Antiviral compounds | Apr 19, 2012 | Issued |
Array
(
[id] => 9307156
[patent_doc_number] => 20140045831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/112581
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53729
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112581 | Bicyclic heterocycle compounds and their uses in therapy | Apr 19, 2012 | Issued |
Array
(
[id] => 8896907
[patent_doc_number] => 08476428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates'
[patent_app_type] => utility
[patent_app_number] => 13/451225
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5150
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451225
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/451225 | Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates | Apr 18, 2012 | Issued |
Array
(
[id] => 9281375
[patent_doc_number] => 20140031342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => '6,7-DIHYDROIMIDAZO [2,1-b] [1,3]OXAZINE BACTERICIDES'
[patent_app_type] => utility
[patent_app_number] => 14/111262
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82092
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111262
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111262 | 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides | Apr 12, 2012 | Issued |
Array
(
[id] => 8336076
[patent_doc_number] => 20120202782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/445644
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8579
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445644 | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | Apr 11, 2012 | Abandoned |
Array
(
[id] => 9530202
[patent_doc_number] => 08754075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => '1,3-oxazines as BACE1 and/or BACE2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/439893
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29070
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439893 | 1,3-oxazines as BACE1 and/or BACE2 inhibitors | Apr 4, 2012 | Issued |
Array
(
[id] => 8522182
[patent_doc_number] => 20120321590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'BRIDGED POLYCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/439959
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31367
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439959 | BRIDGED POLYCYCLIC COMPOUNDS | Apr 4, 2012 | Abandoned |